Nanofluidic digital PCR for improved selection of metastatic colorectal cancer patients to anti-EGFR therapies

被引：0
作者：
Azuara, D. [1 ]
Santos, C. [1 ,2 ]
Lopez-Doriga, A. [3 ]
Montal, R. [1 ,2 ]
Sanjuan, X. [4 ]
Moreno, V. [3 ]
Tabernero, J. [5 ]
Montagut, C. [6 ]
Salazar, R. [1 ,2 ]
Capella, G. [1 ]
机构：
[1] Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain
[2] Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
[3] Catalan Inst Oncol IDIBELL, Biomarkers & Susceptibil Unit, Lhospitalet De Llobregat, Spain
[4] Univ Hosp Bellvitge IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Spain
[5] Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[6] Hosp del Mar, Dept Med Oncol, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
699
引用
收藏
页码：S154 / S155
页数：2
相关论文
共 50 条
  • [31] Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer
    Maria Carmela Annunziata
    Alfonso De Stefano
    Gabriella Fabbrocini
    Silvana Leo
    Paolo Marchetti
    Maria Concetta Romano
    Ivana Romano
    Clinical Drug Investigation, 2019, 39 : 825 - 834
  • [32] Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context
    Niedersüß-Beke D.
    Simon J.
    Schiffinger M.
    Mader R.M.
    memo - Magazine of European Medical Oncology, 2018, 11 (4) : 322 - 329
  • [33] Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Vernieri, Claudio
    Siravegna, Giulia
    Mennitto, Alessia
    Berenato, Rosa
    Perrone, Federica
    Gloghini, Annunziata
    Tamborini, Elena
    Lonardi, Sara
    Morano, Federica
    Picciani, Benedetta
    Busico, Adele
    Volpi, Chiara Costanza
    Martinetti, Antonia
    Battaglin, Francesca
    Bossi, Ilaria
    Pellegrinelli, Alessio
    Milione, Massimo
    Cremolini, Chiara
    Di Bartolomeo, Maria
    Bardelli, Alberto
    de Braud, Filippo
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2414 - 2422
  • [34] MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
    Cappuzzo, Federico
    Sacconi, Andrea
    Landi, Lorenza
    Ludovini, Vienna
    Biagioni, Francesca
    D'Incecco, Armida
    Capodanno, Alessandra
    Salvini, Jessica
    Corgna, Enrichetta
    Cupini, Samanta
    Barbara, Cecilia
    Fontanini, Gabriella
    Crino, Lucio
    Blandino, Giovanni
    CLINICAL COLORECTAL CANCER, 2014, 13 (01) : 37 - U62
  • [35] Use of anti-EGFR agents among elderly patients with metastatic colorectal cancer (mCRC).
    D'Silva, Ashley James
    Dotan, Efrat
    Kloth, Dwight D.
    Beck, Andrew
    Cohen, Steven J.
    Denlinger, Crystal Shereen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [36] Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
    Cremolini, Chiara
    Montagut, Clara
    Ronga, Philippe
    Venturini, Filippo
    Yamaguchi, Kensei
    Stintzing, Sebastian
    Sobrero, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [37] Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies
    Mizukami, Takuro
    Togashi, Yosuke
    Naruki, Saeko
    Banno, Eri
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Yoneshige, Azusa
    Hayashi, Hidetoshi
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakajima, Takako Eguchi
    Fujino, Takashi
    Boku, Narikazu
    Ito, Akihiko
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    MOLECULAR CARCINOGENESIS, 2017, 56 (01) : 106 - 117
  • [38] Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
    Puzzoni, M.
    Giampieri, R.
    Mariani, S.
    Ziranu, P.
    Pusceddu, V.
    Donisi, C.
    Persano, M.
    Pinna, G.
    Cimbro, E.
    Parrino, A.
    Pretta, A.
    Lai, E.
    Liscia, N.
    Lupi, A.
    Giglio, E.
    Palomba, G.
    Casula, M.
    Pisano, M.
    Palmieri, G.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S543 - S544
  • [39] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    F Di Fiore
    R Sesboüé
    P Michel
    J C Sabourin
    T Frebourg
    British Journal of Cancer, 2010, 103 : 1765 - 1772
  • [40] Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy
    Cristiana Lo Nigro
    Vincenzo Ricci
    Daniela Vivenza
    Cristina Granetto
    Teresa Fabozzi
    Emanuela Miraglio
    Marco C Merlano
    World Journal of Gastroenterology, 2016, (30) : 6944 - 6954
12345